 |
인쇄하기
취소
|
SK's "M-vix", an erectile dysfunction therapy, to market in Korea.
Following a serial market launching of the drugs for erectile dysfunction therapy by Pfizer, Lilly, Bayer, Dong-A and CKD, SK Chemical seems to enter this annual 80 billion won of markets (as of 2006) very soon.
The KFDA approval for "M-vix 50 and 100mg (mirodenafil)" was completed on July 18, said the agency.
M-vix tablet is an enzyme PDE-5 inhibitor to effect by an oral administration,...
The KFDA approval for "M-vix 50 and 100mg (mirodenafil)" was completed on July 18, said the agency.
M-vix tablet is an enzyme PDE-5 inhibitor to effect by an oral administration,...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.